Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Li, Zhi Gen ^a,b   Li, Guang ^a   Zhou, Ying Ling ^a   Chen, Zhu Jun ^a   Yang, Jun Qing ^a   Zhang, Ying ^a   Sun, Shuo ^a   Zhong, Shi Long ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Coronary artery disease; Lipoprotein(a); Major adverse cardiovascular events; Percutaneous coronary intervention; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CHINESE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; ETHNICITY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ARTERY DISEASE; DEATH; FEMALE; GENOTYPING TECHNIQUES; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE;

EID: 84883125321     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-127     Document Type: Article

References (21)

1. Human plasma lipoprotein [a]. Structural properties. Gaubatz JW, Heideman C, Gotto AM Jr, Morrisett JD, Dahlen GH, J Biol Chem 1983 258 7 4582 4589 6220008 (Pubitemid 13080684)
2. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ, Castelli WP, JAMA 1996 276 7 544 548 10.1001/jama.1996.03540070040028 8709403 (Pubitemid 26272299)
3. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study. Berg K, Dahlen G, Christophersen B, Cook T, Kjekshus J, Pedersen T, Clin Genet 1997 52 5 254 261 9520115 (Pubitemid 28068613)
4. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Danesh J, Collins R, Peto R, Circulation 2000 102 10 1082 1085 10.1161/01.CIR.102.10.1082 10973834
5. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG, JAMA 2009 301 22 2331 2339 10.1001/jama.2009.801 19509380
6. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Virani SS, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, Coresh J, Mosley TH, Morrisett JD, Catellier DJ, et al. Circulation 2012 125 2 241 249 10.1161/CIRCULATIONAHA.111.045120 22128224
7. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Erqou S, Kaptoge S, Perry PL, Di-Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J, JAMA 2009 302 4 412 423 19622820
8. Lipoprotein(a), interleukin-10, C-reactive protein, and 8-year outcome after percutaneous coronary intervention. Kardys I, Oemrawsingh RM, Kay IP, Jones GT, McCormick SP, Daemen J, Van-Geuns RJ, Boersma E, Van-Domburg RT, Serruys PW, Clin Cardiol 2012 35 8 482 489 10.1002/clc.21988 22488248
9. Association between Lipoprotein (a) level on admission and the incidence of subsequent cardiovascular events in patients with acute coronary syndrome. Zhou J, Cui X, Jin X, Fu M, Zhong C, Sun A, Hu K, Ge J, Int J Cardiol 2012 158 3 464 466 10.1016/j.ijcard.2012.05.013 22633661
10. Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. Nicholls SJ, Tang WH, Scoffone H, Brennan DM, Hartiala J, Allayee H, Hazen SL, J Lipid Res 2010 51 10 3055 3061 10.1194/jlr.M008961 20601648
11. Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans. Chretien JP, Coresh J, Berthier-Schaad Y, Kao WH, Fink NE, Klag MJ, Marcovina SM, Giaculli F, Smith MW, J Med Genet 2006 43 12 917 923 10.1136/jmg.2006.042119 16840570 (Pubitemid 46080188)
12. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Lanktree MB, Anand SS, Yusuf S, Hegele RA, Circ Cardiovasc Genet 2010 3 1 39 46 10.1161/CIRCGENETICS.109.907642 20160194
13. Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans. Deo RC, Wilson JG, Xing C, Lawson K, Kao WH, Reich D, Tandon A, Akylbekova E, Patterson N, Mosley TH Jr, et al. PLoS One 2011 6 1 14581 10.1371/journal.pone.0014581 21283670
14. A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Luke MM, Kane JP, Liu DM, Rowland CM, Shiffman D, Cassano J, Catanese JJ, Pullinger CR, Leong DU, Arellano AR, et al. Arterioscler Thromb Vasc Biol 2007 27 9 2030 2036 10.1161/ATVBAHA.107.141291 17569884 (Pubitemid 47312314)
15. Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q. Ober C, Nord AS, Thompson EE, Pan L, Tan Z, Cusanovich D, Sun Y, Nicolae R, Edelstein C, Schneider DH, et al. J Lipid Res 2009 50 5 798 806 19124843
16. Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk. Ronald J, Rajagopalan R, Cerrato F, Nord AS, Hatsukami T, Kohler T, Marcovina S, Heagerty P, Jarvik GP, Stroke 2011 42 1 2 9 10.1161/STROKEAHA.110.591230 21127300
17. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, Parish S, Barlera S, Franzosi MG, Rust S, et al. N Engl J Med 2009 361 26 2518 2528 10.1056/NEJMoa0902604 20032323
18. Two rare variants explain association with acute myocardial infarction in an extended genomic region including the apolipoprotein(A) gene. Koch W, Mueller JC, Schrempf M, Wolferstetter H, Kirchhofer J, Schomig A, Kastrati A, Ann Hum Genet 2013 77 1 47 55 10.1111/j.1469-1809.2012.00739.x 23278389
19. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. Helgadottir A, Gretarsdottir S, Thorleifsson G, Holm H, Patel RS, Gudnason T, Jones GT, Van-Rij AM, Eapen DJ, Baas AF, et al. J Am Coll Cardiol 2012 60 8 722 729 10.1016/j.jacc.2012.01.078 22898070
20. The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Kraft HG, Kochl S, Menzel HJ, Sandholzer C, Utermann G, Hum Genet 1992 90 3 220 230 1336760
21. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, et al. Lancet 2000 356 9226 279 284 10.1016/S0140-6736(00)02502-2 11071182 (Pubitemid 30459585)